GXI Gerresheimer AG

36.19USD33.00 EUR · XETRA-0.60%Mkt Cap: 1.25B USDP/E: —

Gerresheimer AG, together with its subsidiaries, provides drug containment solutions in Germany and internationally. The company operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced…

Institutional holders11 on file

Key Statistics

Company
Market Cap1.25B USD
Enterprise Value3.64B USD
Revenue (TTM)2.54B USD
Gross Profit466.42M USD
Net Income (TTM)-351.32M USD
Revenue/Share73.58 USD
Last Price36.19 USD
Fiscal Year EndNov 2025
MR QuarterFeb 2026
Employees13.3K
CountryDE
SectorHealthcare
IndustryMedical Instruments & Supplies
ISINDE000A0LD6E6
Valuation
P/E (Trailing)—
P/E (Forward)13.37
PEG1.23
EV/EBITDA10.28
EV/Revenue1.43
P/S0.49
P/B1.19
EPS (TTM)-13.01 USD
EPS (Forward)2.71 USD
52W Range
16.2794% of range37.51
52W High37.51 USD
52W Low16.27 USD
Profitability
Gross Margin18.32%
Oper. Margin1.65%
EBITDA Margin13.95%
Profit Margin-13.80%
ROE-29.63%
ROA-7.13%
ROIC-2.21%
ROCE-2.26%
Growth
Revenue Growth-0.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF229.81M USD
CapEx (TTM)338.17M USD
FCF Margin-7.58%
FCF Yield-15.42%
Net Debt2.37B USD
Net Debt/EBITDA6.68
Net Debt/FCF—
Balance Sheet
Debt/Equity2.01
Current Ratio1.07
Quick Ratio0.29
Book Value/Sh30.37 USD
Cash/Share5.32 USD
Dividends
Fwd Div Rate0.04 USD
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield0.43%
Payout Ratio3.85%
Ex-Div DateJun 6, 2025
Pay Date—
Analyst Consensus
Rating—
Target (Mean)30.21 USD
Upside (mean)-16.5%
Target Range21.94 USD – 50.45 USD
21.94-16.5% to mean50.45
# Analysts12
Ownership
Shares Out.34.54M
Float32.05M
Insiders10.04%
Institutions67.77%
Technical
SMA 5032.68 (+10.7%)
SMA 20028.08 (+28.9%)
Beta0.47
S&P 52W Chg12.00%
Avg Vol (30d)161.78K
Avg Vol (10d)101.16K
Technical Indicators
RSI (14)62.2
MACD0.5811
MACD Signal0.5863
MACD Hist.-0.0052
BB Upper36.55 USD
BB Middle35.02 USD
BB Lower33.48 USD
BB Width8.76%
ATR (14)1.233 USD
Vol Ratio (20d)0.67x

About Gerresheimer (ETR: GXI)

›

Gerresheimer (ETR: GXI) is listed on Xetra (Frankfurt), where its shares trade in EUR. It belongs to the Medical Instruments & Supplies industry, part of the Healthcare sector, and reports about 13,301 employees.

The shares were at 33.00 EUR on 19 November 2026, up 35.6% over 52 weeks. Its 52-week range is 14.83 EUR to 34.20 EUR: the price is 3.5% below the high and 122.5% above the low.

Its market capitalisation is 1.14B EUR.

Gerresheimer reports return on equity of -29.6%, an operating margin of 1.6% and revenue down 0.8% year over year.

Its debt exceeds its cash by 2.16B EUR, a debt-to-equity ratio of 2.01. Its Piotroski F-score is 3 out of 9, a weak reading of its financial health. 12 analysts cover the stock; their mean price target of 27.54 EUR is 16.5% below the current price. The next earnings report is expected on 25 November 2026.